Penserra Capital Management’s Exact Sciences EXAS Stock Holding History

Penserra Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9	Closed	–	–	1133
2024 Q3	$0	Sell	9 -3	-25%	-$169	﹤0.01%	1164
2024 Q2	$1K	Hold	12	–	–	﹤0.01%	1221
2024 Q1	$0	Hold	12	–	–	﹤0.01%	1303
2023 Q4	$0	Hold	12	–	–	﹤0.01%	1287
2023 Q3	$0	Sell	12 -774	-98%	-$65.7K	﹤0.01%	1277
2023 Q2	$72K	Buy	+786	New	+$61.3K	﹤0.01%	997
2020 Q2	–	Sell	-2,300	Closed	-$188K	–	837
2020 Q1	$188K	Buy	+2,300	New	+$187K	0.01%	459
2019 Q2	–	Sell	-1,207	Closed	-$104K	–	816
2019 Q1	$104K	Buy	+1,207	New	+$103K	0.01%	440
2018 Q4	–	Sell	-336	Closed	-$26K	–	673
2018 Q3	$26K	Buy	+336	New	+$21.9K	﹤0.01%	649

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Penserra Capital Management's EXAS Position: Q4 2024 in Review

Penserra Capital Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 9 shares.

Penserra Capital Management first reported a position in EXAS in Q3 2018 and held it in 9 quarters. The position peaked at $188K in Q1 2020. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

Penserra Capital Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
Penserra Capital Management sold 9 Exact Sciences shares in Q4 2024.
Penserra Capital Management first reported a position in Exact Sciences in Q3 2018 and held it in 9 quarters.
Penserra Capital Management's Exact Sciences position peaked at $188K in Q1 2020.
593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Penserra Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.